KIMBERLY JOHNSON: Open Payments
NPI 1396717104 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 18 payments from 10 companies in 2025. Trend: 2023 $58 · 2024 $159 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $71 |
| Dexcom, Inc. | 3 | $61 |
| Braeburn Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $28 |
| Lilly USA, LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Alkermes, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
Products named: Dexcom G6 Transmitter, BRIXADI, PREVNAR 20, NURTEC ODT, VRAYLAR, MOUNJARO, CAPLYTA, VIVITROL.
Industry payments across MO — which companies pay providers there.
